Smoking remains one of the most preventable causes of disease and premature death worldwide, but its interaction with diabetes—a condition already characterized by heightened infection susceptibility—creates a particularly dangerous synergy. Individuals with diabetes face a compromised immune system due to chronic hyperglycemia, which impairs neutrophil function, reduces cytokine signaling, and slows wound repair. When tobacco use is superimposed, these deficits are amplified, leading to a substantially elevated risk of severe infections, prolonged recovery, and worse clinical outcomes. This article examines the biological mechanisms linking smoking to increased infection risk in people with diabetes, reviews the most common and dangerous infections, and outlines evidence-based strategies for risk reduction through smoking cessation and comprehensive diabetes management.

How Smoking Exacerbates Infection Risk in Diabetes

The relationship between smoking and infection in diabetes is multifaceted, involving direct immune suppression, vascular damage, and alterations in pathogen-host interactions. Understanding these pathways is critical for clinicians and patients alike to appreciate why smoking cessation must be a top priority in diabetes care.

Compromised Immune Function

Nicotine and the thousands of chemicals in cigarette smoke, including tar, carbon monoxide, and oxidative agents, directly impair both innate and adaptive immunity. In people with diabetes, who already exhibit reduced phagocytic activity and lower levels of protective antibodies, smoking further depresses the ability of white blood cells to migrate to infection sites, engulf bacteria, and produce reactive oxygen species needed for killing pathogens. Specifically, studies show that smokers have decreased activity of natural killer cells, altered T‑cell responses, and higher levels of pro‑inflammatory cytokines that paradoxically contribute to tissue damage rather than pathogen clearance. For instance, interleukin‑6 and tumor necrosis factor‑α are often elevated in diabetic smokers, correlating with worse outcomes in pneumonia and wound infections. This immune dysfunction extends to mucosal barriers: smoking damages the epithelium of the respiratory and urinary tracts, making it easier for bacteria to adhere and colonize.

Impaired Circulation and Delayed Wound Healing

Diabetes itself is a major risk factor for peripheral artery disease and microvascular damage, leading to reduced blood flow to extremities. Smoking compounds this by causing vasoconstriction, endothelial dysfunction, and increased blood viscosity. The result is a severely compromised delivery of oxygen, nutrients, and immune cells to tissues. For people with diabetes, even a minor cut or blister can fail to heal properly, quickly escalating into a diabetic foot ulcer. The presence of smoking is associated with a three‑ to four‑fold increased risk of developing a foot ulcer, and once an ulcer forms, healing times are significantly prolonged. Moreover, the risk of surgical site infections after procedures such as amputations or revascularization is markedly higher in smokers, leading to higher reoperation rates and longer hospital stays.

Increased Pathogen Adhesion and Biofilm Formation

Emerging research indicates that cigarette smoke extract can alter the surface properties of cells and tissues, promoting adhesion of bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. In the oral cavity, smoking encourages the formation of dental plaque biofilms, which are linked to severe periodontitis—a common complication in diabetes. This periodontal infection, in turn, exacerbates insulin resistance and glycemic control. Additionally, smoking suppresses the production of antimicrobial peptides in the airways, allowing bacteria to thrive and form biofilms in the lungs, a key factor in chronic obstructive pulmonary disease exacerbations and recurrent pneumonia.

Common Infections with Greater Severity in Smokers with Diabetes

The convergence of immune dysfunction, poor circulation, and increased pathogen colonization means that smokers with diabetes are at heightened risk for a range of infections, each of which tends to be more severe and harder to treat.

Respiratory Infections

Pneumonia, influenza, and COVID‑19 are all more dangerous for this population. Smoking damages the cilia and mucus‑clearing mechanisms of the respiratory tract, while diabetes‑related immune suppression leaves the lungs vulnerable. Hospitalization rates for pneumonia in smokers with diabetes are approximately two‑fold higher compared with non‑smoking diabetics, and mortality from influenza‑related complications rises sharply. During the SARS‑CoV‑2 pandemic, smokers with diabetes were identified as a particularly high‑risk subgroup, with greater odds of severe illness, need for mechanical ventilation, and death. A meta‑analysis published in Diabetes Care (2021) reported that smoking doubled the risk of severe COVID‑19 outcomes in individuals with diabetes, independent of age and other comorbidities.

Urinary Tract and Kidney Infections

Urinary tract infections (UTIs) are common in women with diabetes, but smoking adds another layer of risk. Tobacco use is associated with increased bacterial colonization of the perineal area and altered bladder defenses. Smokers with diabetes have a higher incidence of pyelonephritis (kidney infection), which can lead to bacteremia, abscess formation, and even permanent renal impairment. The presence of diabetes also complicates treatment because certain antibiotics must be dose‑adjusted for renal function—a variable that smoking can further worsen by accelerating diabetic nephropathy.

Skin and Soft Tissue Infections

Diabetic foot infections represent one of the most feared complications. Smoking not only increases the risk of initial ulceration but also delays healing and promotes biofilm formation. The combination of neuropathy and vascular disease means that infections can spread rapidly to deeper structures, including bone (osteomyelitis). Smokers with diabetes are significantly more likely to require amputation compared with non‑smokers. A large cohort study from the Veterans Affairs system found that current smoking was associated with a 50% increase in the risk of major amputation among diabetic patients with foot ulcers. Similarly, cellulitis and abscesses elsewhere on the body are more common and more prone to recurrence in smokers.

Oral Infections and Periodontitis

Diabetes and smoking are the two strongest independent risk factors for periodontitis, a chronic inflammatory disease of the gums. When combined, they act synergistically: smokers with diabetes have more severe attachment loss, deeper periodontal pockets, and higher rates of tooth loss compared with either condition alone. The inflammation from periodontitis worsens insulin resistance, making glycemic control even more difficult. Periodontitis also raises the risk of other infections—bacteria can enter the bloodstream and contribute to endocarditis or prosthetic joint infections. Regular dental care and smoking cessation are essential but often underemphasized components of diabetes management.

Long‑Term Consequences: Hospitalizations, Mortality, and Economic Burden

The cumulative effect of increased infection frequency and severity translates into measurable outcomes that affect both individual health and healthcare systems.

Higher Hospitalization Rates

Smokers with diabetes are hospitalized for infections at rates roughly 40–60% higher than non‑smokers with diabetes, after adjusting for age, sex, and glycemic control. These hospital stays are often longer (by an average of 2–4 days), require more intensive care, and are more likely to result in readmission within 30 days. Common admission diagnoses include pneumonia, urinary sepsis, and diabetic foot infections. Each hospitalization imposes physical and psychological stress on the patient and adds significant cost, with estimates suggesting that each infectious episode adds thousands of dollars to annual diabetes‑related healthcare expenses.

Increased Mortality

Several large epidemiological studies have documented that smoking confers a two‑fold increase in all‑cause mortality among people with diabetes, with a substantial proportion of excess deaths attributable to infections. For example, the Nurses’ Health Study and the Health Professionals Follow‑up Study both found that current smokers with diabetes had a significantly higher risk of death from infectious diseases—especially pneumonia and influenza—compared with never‑smokers. Even after quitting, former smokers experience a residual increased risk for several years, emphasizing the importance of early intervention.

Economic Burden

Beyond patient suffering, the financial impact is enormous. The combination of diabetes and smoking costs the U.S. healthcare system an estimated $30 billion annually in direct medical costs and lost productivity. A significant fraction of this is linked to preventable infections. Reducing smoking prevalence among diabetic patients would not only save lives but also lower healthcare expenditures—a compelling argument for policy‑level interventions and insurance coverage of cessation programs.

Evidence from Research and Clinical Guidelines

Robust evidence underpins the recommendations to screen for tobacco use in all people with diabetes and to offer cessation support routinely. The American Diabetes Association’s Standards of Medical Care in Diabetes (2024) explicitly state: “All patients with diabetes should be advised not to use cigarettes, e‑cigarettes, and other tobacco products.” The U.S. Centers for Disease Control and Prevention (CDC) also highlights the heightened infection risk in smokers with diabetes and recommends smoking cessation as a key strategy to prevent complications. Furthermore, systematic reviews in journals such as Diabetes/Metabolism Research and Reviews and Diabetologia have quantified the infection‑related harm. For instance, a 2022 meta‑analysis of 15 cohort studies found that smoking increased the odds of any infection by 70% in people with diabetes (OR 1.70, 95% CI 1.45–2.00).

External resources patients and providers can consult include: CDC Tips from Former Smokers: Diabetes and Smoking, American Diabetes Association: Smoking Cessation Resources, and World Health Organization: Tobacco Fact Sheet.

Smoking Cessation: A Critical Intervention to Reduce Infection Risk

While the risks are grave, the benefits of quitting smoking are substantial and rapid. Within weeks of cessation, immune function begins to improve, circulation increases, and the risk of infection declines. For people with diabetes, smoking cessation is arguably one of the most effective strategies to improve overall health outcomes, alongside glycemic control and routine vaccinations.

Pharmacotherapy Options

Nicotine replacement therapy (NRT)—available in patches, gum, lozenges, inhalers, and nasal sprays—has strong evidence for increasing quit rates. For patients with diabetes, NRT is considered safe and does not significantly affect blood glucose levels. Prescription medications such as varenicline (Chantix) and bupropion (Zyban) are also highly effective. Varenicline, a partial nicotine receptor agonist, has been shown to double long‑term abstinence rates. However, clinicians should monitor for rare neuropsychiatric side effects, especially in patients with comorbid depression. A 2023 randomized trial published in JAMA confirmed that varenicline combined with behavioral support produced the highest quit rates among smokers with diabetes. Importantly, these medications can be safely prescribed in primary care settings, and many insurance plans cover them.

Behavioral Support and Digital Interventions

Counseling—whether individual, group, or telephone‑based—enhances the effectiveness of pharmacotherapy. The national quitline (1‑800‑QUIT‑NOW) provides free coaching and sometimes free NRT. For patients who prefer digital tools, mobile apps like Smokefree.gov and quitSTART offer personalized plans and tracking. For people with diabetes, integrating smoking cessation with diabetes education can be particularly effective; for instance, discussing how each cigarette elevates blood pressure and impairs insulin sensitivity may motivate behavior change. Healthcare providers should use every clinical encounter to assess readiness to quit and provide brief advice.

Integration into Diabetes Care

Given the high priority of smoking cessation for diabetes management, the ADA recommends the “5 A’s” approach: Ask about tobacco use, Advise to quit, Assess willingness to quit, Assist with quit plan, and Arrange follow‑up. Electronic health record prompts can automate screening and link patients to cessation resources. Additionally, diabetes clinics should consider co‑locating cessation counselors or offering nicotine replacement during routine visits. The combination of structured support and pharmacotherapy can achieve quit rates of 25–30% at one year—a success rate that translates directly into reduced infections, fewer hospitalizations, and better quality of life.

Practical Recommendations for Patients and Providers

While systemic changes are important, individual actions can also reduce risk. The following strategies are recommended for all adults with diabetes who smoke:

  • Commit to a quit date and tell family and friends for accountability. Use a cessation plan that includes both medication and counseling.
  • Manage blood sugar aggressively while quitting, as stress and nicotine withdrawal can temporarily affect glucose levels. Work with a diabetes educator to adjust insulin or oral medications as needed.
  • Stay up‑to‑date on vaccinations: pneumococcal vaccine, annual influenza shot, COVID‑19 booster, and hepatitis B vaccine (if not already immune). These are especially important for smokers with diabetes to prevent vaccine‑preventable infections.
  • Inspect feet daily and report any cuts, blisters, or signs of infection immediately. Smokers with neuropathy must be vigilant because healing is slower and infection risk is higher.
  • Maintain excellent oral hygiene—brush twice daily, floss, and schedule dental visits every six months. Periodontal disease is easier to control if smoking ceases.
  • Avoid secondhand smoke exposure, which also impairs immune function and glucose metabolism. Encourage household members to quit as well.

For healthcare providers, the evidence is clear: tobacco use should be considered a vital sign in diabetes care. Document smoking status at every visit, offer evidence‑based cessation support, and refer to specialty programs when available. Consider using biometric feedback—such as showing patients an A1c trend or a peripheral circulation assessment—to illustrate the real impact of smoking. Collaboration with cardiology, podiatry, and infectious disease specialists can further optimize outcomes for complex patients.

Conclusion

Smoking dramatically amplifies the already elevated infection risk faced by people with diabetes through immune suppression, vascular damage, and enhanced bacterial colonization. The consequences—more frequent and severe infections, prolonged hospital stays, higher amputation rates, and increased mortality—are profound and preventable. Smoking cessation remains one of the most powerful interventions to reduce infection risk and improve overall health in this population. By combining pharmacotherapy, behavioral support, and integration into routine diabetes care, clinicians can help patients achieve lasting abstinence. For people with diabetes, every cigarette avoided is a step toward fewer infections, better glycemic control, and a longer, healthier life.

This article is for educational purposes and does not replace medical advice. For personalized guidance on smoking cessation and diabetes management, consult your healthcare provider.